The National MS Society has awarded $4.6 million in funding for five research projects aiming to help restore lost function ...

Sanofi stopped a Phase 2 study of oditrasertib in relapsing and progressive MS after it failed to lower blood NfL levels ...

Curiously, columnist Leigh Anne Nelson can't tolerate wearing socks. It's one of several foot symptoms of her MS.

People with MS may have a slightly higher risk of developing cancer than the general population, per a 10-year population ...

Adding Tecfidera to an immune tolerizing cell therapy could maximize therapeutic benefits for MS patients, according to a ...

Better adherence to an at-home therapy regimen with the PoNS device was linked to greater improvements in walking function in ...

Faced with the loss of cognitive abilities from multiple sclerosis, columnist Ben Hofmeister grapples with a bout of depression.

A study involving identical twins suggests alterations in immune cells called CD8 T-cells may be early drivers of ...